Medical University Of Gdansk

The sponsor funds studies in classical Hodgkin lymphoma, refractory and relapsed Hodgkin lymphoma, and systemic mastocytosis. These trials address both early-stage disease and treatment-resistant haematologic malignancies.

• Hodgkin lymphoma management
• Resistant and relapsed lymphoma care
• Systemic mastocytosis with skin involvement

Its clinical research also examines immune-targeted approaches and post-treatment disease control in haematological conditions.

Clinical work includes Marfan syndrome and a broader group of heritable thoracic aortic diseases, including Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, and other rare aortopathy syndromes.

• Aortic root dilatation
• Thoracic aortic aneurysm and dissection syndromes
• Paediatric and young adult heritable aortic disease

Additional interest is shown in multisystem connective tissue disorders with vascular fragility and inherited structural abnormalities.

The sponsor is active in hepatoblastoma and hepatocellular carcinoma in children and adolescents, with attention to malignant liver tumours requiring specialised surgical and systemic management.

• Primary paediatric liver cancer
• Hepatoblastoma and hepatocarcinoma
• Surgical and disease-control strategies in liver malignancy

This area reflects interest in treatment selection for rare paediatric cancers and optimisation of care in liver tumour subtypes.

Research also covers ulcerative colitis, duchenne muscular dystrophy, nephrotic syndrome, and fibrotic interstitial lung disease, including pulmonary fibrosis after viral injury. These studies span immune-mediated, genetic, renal, and respiratory disease domains.

• Inflammatory bowel disease
• Muscular dystrophy and cardiac involvement
• Nephrotic syndrome and fibrotic lung disease

Its portfolio further includes anxiety-depressive symptoms associated with cardiac disease and other multisystem complications linked to chronic illness.